團結實驗
團結實驗（Solidarity trial）是由世界衛生組織和合作夥伴進行的一項多國III-IV期臨床試驗，旨在比較四種未經測試的2019冠狀病毒病治療方法。該試驗於2020年3月18日正式對外宣佈[1]，2020年5月，世衛組織宣佈成立一個國際聯盟，負責同時開發多種候選疫苗以預防2019冠狀病毒病，並將這項工作稱為疫苗團結試驗。 [2]截至2021年8月6日，已經有來自30個國家的12000名患者參與團結實驗[3]。
參考文獻
編輯- ^ UN health chief announces global 'solidarity trial' to jumpstart search for COVID-19 treatment. United Nations, World Health Organization. 18 March 2020 [2 April 2020]. （原始內容存檔於2020-03-23） （英語）.
- ^ Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine. World Health Organization. 2020-04-27 [2020-05-02]. （原始內容存檔於2020-04-24）.
It is vital that we evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable. To increase the chances of success (given the high level of attrition during vaccine development), we must test all candidate vaccines until they fail. WHO is working to ensure that all of them have the chance of being tested at the initial stage of development. The results for the efficacy of each vaccine are expected within three to six months and this evidence, combined with data on safety, will inform decisions about whether it can be used on a wider scale
- ^ 'Solidarity' clinical trial for COVID-19 treatment. www.who.int. World Health Organization. [2020-04-22]. （原始內容存檔於2020-10-12） （英語）.